Doherty Catherine T.'s Form 4 filing
Quest Diagnostics Inc (DGX) · filed Mar 8, 2023
- Accession no.
- 0001022079-23-000069
- Filed
- Mar 8, 2023
- Trade date
- Mar 6-7, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $745.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Doherty Catherine T.CIK 0001520897 | Officer (SVP, Regional Businesses) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2023 | Common Stock | AGrant or awardAcquired | +9,917 | $147.86 | +$1,466,327.62 | 77,727 | Direct | |
| Mar 6, 2023 | Common Stock | FTax withholdingDisposed | −4,610 | $147.86 | −$681,634.6 | 73,117 | Direct | |
| Mar 7, 2023 | Common Stock | SSaleDisposed | −5,307 | $140.55 | −$745,898.85 | 67,810 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.